プラズマGABAとビガバトリンによる発作制御

Epileptogenicity and pathology - Under consideration of ablative approaches.

Epilepsy research·2018

Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.

Epilepsy & behavior case reports·2017

Automatic multimodal detection for long-term seizure documentation in epilepsy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2017

Comparative assessment of Vibrio virulence in marine fish larvae.

Journal of fish diseases·2017

Single-dose intravenous administration of antiepileptic drugs induces rapid and reversible remodeling in the brain: Evidence from a voxel-based morphometry evaluation of valproate and levetiracetam in rhesus monkeys.

Neuroscience·2015

Epilepsy in the elderly: restrictions, fears, and quality of life.

Acta neurologica Scandinavica·2014

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

AI product liability under EU and Canadian laws.

Frontiers in artificial intelligence·2026

[THE ACTUAL ISSUES OF MANDATORY LABELING OF MEDICAL ARTICLES].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026

Pharmaceutical Innovation and Drug Policy: The Case of the 1984 Hatch-Waxman Act.

PloS one·2026

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies.

Neurourology and urodynamics·2026

Decreased Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification in Kentucky and West Virginia.

Substance use & addiction journal·2026

Contraindications of femoral implants in primary total hip arthroplasty : legal implications and strategies for orthopaedic surgeons.

Bone & joint open·2026

関連する実験動画

プラズマGABAとビガバトリンによる発作制御

関連する概念動画

Epileptogenicity and pathology - Under consideration of ablative approaches.

Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population.

Automatic multimodal detection for long-term seizure documentation in epilepsy.

Comparative assessment of Vibrio virulence in marine fish larvae.

Single-dose intravenous administration of antiepileptic drugs induces rapid and reversible remodeling in the brain: Evidence from a voxel-based morphometry evaluation of valproate and levetiracetam in rhesus monkeys.

Epilepsy in the elderly: restrictions, fears, and quality of life.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

AI product liability under EU and Canadian laws.

[THE ACTUAL ISSUES OF MANDATORY LABELING OF MEDICAL ARTICLES].

Pharmaceutical Innovation and Drug Policy: The Case of the 1984 Hatch-Waxman Act.

Prior Authorization for Sacral Nerve Stimulation in the Era of WISeR: Evaluation of U.S. Payer Coverage Policies.

Decreased Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification in Kentucky and West Virginia.

Contraindications of femoral implants in primary total hip arthroplasty : legal implications and strategies for orthopaedic surgeons.

関連する実験動画

プラズマGABAとビガバトリンによる発作制御

関連する概念動画

関連記事